- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Pages tagged "Research"
Posted on Blogs by · February 07, 2013 9:36 AMEarlier in the week, we posted a blog from one of our Board Members, Dr. Karen Munkacy, who is working hard on making sure that implementation of Massachusetts’ medical cannabis program goes smoothly. Of course, Massachusetts scored a huge victory for safe access when they passed their initiative last November, but few people understand that this is only the first step towards ensuring patients get access to legal medicine in a state. The battle we’re fighting now, with the help of advocates like Dr. Munkacy, is making sure that the rules and regulations for the program are composed in a way that most benefits the patients.
The good news is that what has truly been a battle in other states has become a welcome and open dialogue with the MA Department of Public Health (DPH), who is charged with the difficult task of interpreting the initiative while writing the program’s regulations. In fact, DPH is actually looking for public input on a number of issues and are holding Townhall-type meetings called “Listening Sessions” in the next few weeks. This is a great opportunity for MA patients and advocates to submit comments on these seven issues:
- Patient eligibility and debilitating conditions
- Guidance and training for physicians
- Operations of a medical marijuana treatment center, including security requirements
- 60-day supply of marijuana
- Use of marijuana in food products for medical purposes
- Requirements for hardship cultivation registrations
- Monitoring of medical marijuana treatment centers and enforcement of regulations
If you are planning on testifying in person, make sure your testimony addresses only these listed issues. Also, residents of MA can submit written comments on these issues if they cannot make it to testify at one of the sessions. ASA is encouraged by the amazing example that MA DPH is setting for their colleagues in other states through their transparency and disposition to hear stakeholder input. Through DPH’s willingness to work with the medical cannabis community, MA will soon have a functional and patient-oriented program to serve the needs of their patients. Hopefully this means that suffering patients in the Bay State won’t have to wait as long as their brothers and sisters in New Jersey (over 2 years) to receive legal medicine!